| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1017/S1462399408000847 |
| P698 | PubMed publication ID | 18928579 |
| P2093 | author name string | William W Hall | |
| Barbara Roe | |||
| P2860 | cites work | HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor | Q22242268 |
| Hepatitis C virus non-structural protein NS5A interacts with FKBP38 and inhibits apoptosis in Huh7 hepatoma cells | Q24297145 | ||
| Hepatitis C virus NS5A as a potential viral Bcl-2 homologue interacts with Bax and inhibits apoptosis in hepatocellular carcinoma | Q24316497 | ||
| Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus | Q24336255 | ||
| Expression of hepatitis C virus proteins induces distinct membrane alterations including a candidate viral replication complex | Q24537657 | ||
| The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells | Q24564509 | ||
| Cerebrospinal fluid interferon-gamma-inducible protein 10 (IP-10, CXCL10) in HIV-1 infection | Q81037707 | ||
| Molecular virology of hepatitis C virus (HCV): 2006 update | Q27473115 | ||
| The hepatitis C virus p7 protein forms an ion channel that is inhibited by long-alkyl-chain iminosugar derivatives | Q27477454 | ||
| Association of pretreatment serum interferon inducible protein 10 levels with sustained virological response to peginterferon plus ribavirin therapy in genotype 1 infected patients with chronic hepatitis C | Q27478305 | ||
| The hepatitis C virus and immune evasion: non-structural 3/4A transgenic mice are resistant to lethal tumour necrosis factor mediated liver disease | Q27478330 | ||
| Plasma chemokine levels correlate with the outcome of antiviral therapy in patients with hepatitis C | Q27480302 | ||
| Hepatitis C Virus p7 Protein Is Crucial for Assembly and Release of Infectious Virions | Q27480902 | ||
| Memory CD8+ T cells are required for protection from persistent hepatitis C virus infection | Q27485119 | ||
| CD8 Epitope Escape and Reversion in Acute HCV Infection | Q27485189 | ||
| Biosynthesis and biochemical properties of the hepatitis C virus core protein | Q27485987 | ||
| Internal ribosome entry site within hepatitis C virus RNA | Q27486220 | ||
| Analysis of successful immune responses in persons infected with hepatitis C virus | Q27860698 | ||
| Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial | Q27860949 | ||
| Determinants of viral clearance and persistence during acute hepatitis C virus infection | Q28131757 | ||
| Hepatitis C in the HIV-Infected Person | Q28206126 | ||
| Interferon (IFN)-gamma-inducible protein-10: association with histological results, viral kinetics, and outcome during treatment with pegylated IFN-alpha 2a and ribavirin for chronic hepatitis C virus infection | Q28262594 | ||
| Peginterferon Alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients | Q28274666 | ||
| Peginterferon Alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons | Q28274676 | ||
| rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA | Q28279513 | ||
| HIV-1: fifteen proteins and an RNA | Q28284280 | ||
| Regulating the functions of the HIV-1 matrix protein | Q28296727 | ||
| Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial | Q28298301 | ||
| CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1 | Q28646859 | ||
| Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators | Q29547281 | ||
| Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: a randomized study of treatment duration and ribavirin dose | Q29547886 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| Unravelling hepatitis C virus replication from genome to function | Q29620056 | ||
| Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy | Q29620140 | ||
| Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection | Q29620141 | ||
| The p7 protein of hepatitis C virus forms an ion channel that is blocked by the antiviral drug, Amantadine | Q29620670 | ||
| Mitochondrial injury, oxidative stress, and antioxidant gene expression are induced by hepatitis C virus core protein | Q29620682 | ||
| HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help | Q29620766 | ||
| A second hepatitis C virus-encoded proteinase | Q29620770 | ||
| Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C | Q29620791 | ||
| Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection | Q29620795 | ||
| The outcome of hepatitis C virus infection is predicted by escape mutations in epitopes targeted by cytotoxic T lymphocytes | Q30004698 | ||
| Liver cell apoptosis in chronic hepatitis C correlates with histological but not biochemical activity or serum HCV-RNA levels | Q42998514 | ||
| Impaired allostimulatory function of dendritic cells in chronic hepatitis C infection | Q43001795 | ||
| Relation between HIV-1 and hepatitis C viral load in patients with hemophilia | Q43031909 | ||
| Hepatitis C virus particle detected by immunoelectron microscopic study | Q43035885 | ||
| Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin | Q43036381 | ||
| Influence of HCV genotype and co-infection with human immunodeficiency virus on CD4(+) and CD8(+) T-cell responses to hepatitis C virus | Q43036765 | ||
| Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial | Q43040301 | ||
| Elevated serum levels of interferon- gamma -inducible protein-10 in patients coinfected with hepatitis C virus and HIV. | Q43040379 | ||
| Coinfection with hepatitis viruses and outcome of initial antiretroviral regimens in previously naive HIV-infected subjects | Q43040457 | ||
| Increased expression of T cell chemokines and their receptors in chronic hepatitis C: relationship with the histological activity of liver disease | Q43040925 | ||
| Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation. | Q43046782 | ||
| Hepatitis C virus and HIV envelope proteins collaboratively mediate interleukin-8 secretion through activation of p38 MAP kinase and SHP2 in hepatocytes | Q43047968 | ||
| Hepatitis C virus core and nonstructural protein 3 proteins induce pro- and anti-inflammatory cytokines and inhibit dendritic cell differentiation. | Q43048494 | ||
| Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections | Q43851688 | ||
| Survival in patients with HIV infection and viral hepatitis B or C: a cohort study | Q44054447 | ||
| Hepatitis C in the HIV (human immunodeficiency virus) Atlanta V.A. (Veterans Affairs Medical Center) Cohort Study (HAVACS): the effect of coinfection on survival | Q45334756 | ||
| Hepatic inflammatory cytokine mRNA expression in hepatitis C virus-human immunodeficiency virus co-infection | Q45397978 | ||
| Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART. | Q45398496 | ||
| Liver-related deaths in persons infected with the human immunodeficiency virus: the D:A:D study | Q45413375 | ||
| Increased hepatocyte fas expression and apoptosis in HIV and hepatitis C virus coinfection | Q45423509 | ||
| Influence of hepatitis C virus infection on HIV-1 disease progression and response to highly active antiretroviral therapy | Q45424761 | ||
| Intra-hepatic messenger RNA levels for interferons and related genes in hepatitis C virus/HIV co-infected patients | Q45650928 | ||
| Effect of antiretroviral therapy on liver-related mortality in patients with HIV and hepatitis C virus coinfection | Q45707657 | ||
| Caspase activation correlates with the degree of inflammatory liver injury in chronic hepatitis C virus infection | Q45735446 | ||
| Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study | Q45739390 | ||
| Immune responses to hepatitis C and non-hepatitis C antigens in hepatitis C virus infected and HIV-1 coinfected patients | Q45739617 | ||
| Hepatitis C virus co-infection is a negative prognostic factor for clinical evolution in human immunodeficiency virus-positive patients | Q45741644 | ||
| The impact of co-infection with hepatitis C virus and HIV on the tolerability of antiretroviral therapy | Q45743067 | ||
| Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The Multivirc Group | Q45747079 | ||
| Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein | Q45758348 | ||
| Human immunodeficiency virus infection modifies the natural history of chronic parenterally-acquired hepatitis C with an unusually rapid progression to cirrhosis | Q45763095 | ||
| Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity | Q45764886 | ||
| Coinfection of hepatitis C virus with human immunodeficiency virus and progression to AIDS. Italian Seroconversion Study. | Q45788301 | ||
| Hepatitis C virus infection in the asymptomatic British blood donor | Q45790380 | ||
| Trans-activator gene of human T-lymphotropic virus type III (HTLV-III). | Q45838520 | ||
| Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. | Q46719182 | ||
| Expression of the chemokine IP-10 correlates with the accumulation of hepatic IFN-gamma and IL-18 mRNA in chronic hepatitis C but not in hepatitis B. | Q47850485 | ||
| Hepatitis C recurrence and fibrosis progression are not increased after living donor liver transplantation: a single-center study of 289 patients. | Q52926404 | ||
| Oral IDN-6556, an antiapoptotic caspase inhibitor, may lower aminotransferase activity in patients with chronic hepatitis C. | Q53538258 | ||
| The C-X-C chemokine IP-10 stimulates HIV-1 replication. | Q54781231 | ||
| HIV/HBV and HIV/HCV coinfection, and outcomes following highly active antiretroviral therapy | Q59647437 | ||
| Downregulation of cell surface CD4 by nef | Q60160344 | ||
| ICE inhibitor YVADcmk is a potent therapeutic agent against in vivo liver apoptosis | Q71527279 | ||
| ICE-protease inhibitors block murine liver injury and apoptosis caused by CD95 or by TNF-alpha | Q73203922 | ||
| Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease | Q73470103 | ||
| Hepatocellular carcinoma in HIV-infected patients with chronic hepatitis C | Q73485576 | ||
| Interferons and interferon (IFN)-inducible protein 10 during highly active anti-retroviral therapy (HAART)-possible immunosuppressive role of IFN-alpha in HIV infection | Q73486184 | ||
| Detection of elevated caspase activation and early apoptosis in liver diseases | Q73806052 | ||
| Antigen-specific T-lymphocyte proliferative responses during highly active antiretroviral therapy (HAART) of HIV-1 infection | Q77324015 | ||
| An N-terminal amphipathic helix in hepatitis C virus (HCV) NS4B mediates membrane association, correct localization of replication complex proteins, and HCV RNA replication | Q40162016 | ||
| Signal transducer and activator of transcription factor 1 mediates apoptosis induced by hepatitis C virus and HIV envelope proteins in hepatocytes | Q40245620 | ||
| Molecular mechanism of hepatic injury in coinfection with hepatitis C virus and HIV. | Q40355507 | ||
| HIV and hepatitis C co-infection | Q40395267 | ||
| Hepatitis C virus core protein modulates TRAIL-mediated apoptosis by enhancing Bid cleavage and activation of mitochondria apoptosis signaling pathway. | Q40460735 | ||
| Hepatitis C virus core, NS3, NS5A, NS5B proteins induce apoptosis in mature dendritic cells. | Q40472043 | ||
| The NS3 protein of hepatitis C virus induces caspase-8-mediated apoptosis independent of its protease or helicase activities | Q40505463 | ||
| The Hepatitis C virus NS5A protein activates a phosphoinositide 3-kinase-dependent survival signaling cascade | Q40601685 | ||
| HCV NS5A interacts with p53 and inhibits p53-mediated apoptosis | Q40720204 | ||
| Hepatitis C virus core protein inhibits apoptosis via enhanced Bcl-xL expression. | Q40728906 | ||
| Characterization of liver T-cell receptor gammadelta T cells obtained from individuals chronically infected with hepatitis C virus (HCV): evidence for these T cells playing a role in the liver pathology associated with HCV infections | Q40807254 | ||
| Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes | Q41054119 | ||
| Patients co-infected with human immunodeficiency virus and hepatitis C virus demonstrate higher levels of hepatic HCV RNA. | Q41710040 | ||
| Hepatitis C virus non-structural protein 4 suppresses Th1 responses by stimulating IL-10 production from monocytes. | Q42981482 | ||
| Impaired clearance of virus-infected hepatocytes in transgenic mice expressing the hepatitis C virus polyprotein. | Q42983493 | ||
| Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV. | Q42986154 | ||
| Intrahepatic CD4+ cell depletion in hepatitis C virus/HIV-coinfected patients | Q42987023 | ||
| The cellular immune responses induced in the follow-up of interferon-alpha treated patients with chronic hepatitis C may determine the therapy outcome | Q42990947 | ||
| Prevalence of antibodies against hepatitis C virus in the adult German population. | Q42995977 | ||
| Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection. | Q42996799 | ||
| Intrahepatic cytokine expression is downregulated during HCV/HIV co-infection | Q42997297 | ||
| Antigen-specific immune responses and liver histology in HIV and hepatitis C coinfection | Q33730915 | ||
| Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone | Q33847737 | ||
| Oxidative damage, pro-inflammatory cytokines, TGF-alpha and c-myc in chronic HCV-related hepatitis and cirrhosis. | Q33867295 | ||
| The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt | Q33884428 | ||
| Human hepatitis C virus NS5A protein alters intracellular calcium levels, induces oxidative stress, and activates STAT-3 and NF-kappa B. | Q33933056 | ||
| The trans-activator gene of HTLV-III is essential for virus replication | Q34161962 | ||
| Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory | Q34190038 | ||
| How hepatitis C virus counteracts the interferon response: the jury is still out on NS5A. | Q34250843 | ||
| Immunopathogenesis of hepatitis C viral infection: Th1/Th2 responses and the role of cytokines | Q34283828 | ||
| Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant | Q34499902 | ||
| Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist | Q34900183 | ||
| Mismatch repair genes (hMLH1, hPMS1, hPMS2, GTBP/hMSH6, hMSH2) in the pathogenesis of hepatocellular carcinoma | Q35010942 | ||
| Cytokine profile in Egyptian hepatitis C virus genotype-4 in relation to liver disease progression | Q35165855 | ||
| Pathophysiology of hepatitis C virus infection and related liver disease | Q35703872 | ||
| Changes in paracrine interleukin-2 requirement, CCR7 expression, frequency, and cytokine secretion of human immunodeficiency virus-specific CD4+ T cells are a consequence of antigen load | Q35784804 | ||
| Production of tumor necrosis factor alpha and interleukin 1 beta by monocytic cells infected with human immunodeficiency virus | Q35813766 | ||
| Decreased CXCR3+ CD8 T cells in advanced human immunodeficiency virus infection suggest that a homing defect contributes to cytotoxic T-lymphocyte dysfunction | Q35947828 | ||
| The packaging and maturation of the HIV-1 Pol proteins | Q36002732 | ||
| HCV-HIV coinfection: simple messages from a complex disease | Q36026387 | ||
| Overview of cell death signaling pathways | Q36051647 | ||
| Apoptosis: a mechanism of acute and chronic liver injury | Q36160716 | ||
| Options for treatment of hepatitis C in HIV-infected persons | Q36342864 | ||
| Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-transcriptional mechanisms | Q36352092 | ||
| Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells | Q36361823 | ||
| Incorporation of Vpr into human immunodeficiency virus type 1 virions: requirement for the p6 region of gag and mutational analysis. | Q36655127 | ||
| The apoptosome: signalling platform of cell death | Q36766418 | ||
| Cell suicide and caspases | Q36768874 | ||
| Cellular and molecular mechanisms of liver injury | Q36908855 | ||
| Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus | Q37374471 | ||
| Hepatitis C and Human Immunodeficiency Virus Envelope Proteins Cooperatively Induce Hepatocytic Apoptosis via an Innocent Bystander Mechanism | Q39281648 | ||
| Hepatitis C and progression of HIV disease | Q39607141 | ||
| Rules of chemokine receptor association with T cell polarization in vivo | Q39947109 | ||
| P921 | main subject | hepatitis C | Q154869 |
| Hepatitis C virus | Q708693 | ||
| molecular interaction | Q33059490 | ||
| P304 | page(s) | e30 | |
| P577 | publication date | 2008-10-20 | |
| P1433 | published in | Expert Reviews in Molecular Medicine | Q15755244 |
| P1476 | title | Cellular and molecular interactions in coinfection with hepatitis C virus and human immunodeficiency virus | |
| P478 | volume | 10 |
| Q85624158 | A case of severe acute hepatitis C and delayed antibody production due to rituximab therapy |
| Q33632714 | A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection |
| Q37586815 | Advances in sexually transmitted infections of the gastrointestinal tract |
| Q64249929 | Antiviral Activities of Silymarin and Derivatives |
| Q42229509 | Genome-wide mRNA and miRNA analysis of peripheral blood mononuclear cells (PBMC) reveals different miRNAs regulating HIV/HCV co-infection |
| Q35122931 | HIV-1 infected peripheral blood mononuclear cells modulate the fibrogenic activity of hepatic stellate cells through secreted TGF-β and JNK signaling |
| Q34561257 | HIV/HCV co-infection: pathogenesis, clinical complications, treatment, and new therapeutic technologies |
| Q22299128 | Hepatitis C virus infection in the immunocompromised host: a complex scenario with variable clinical impact |
| Q39309289 | Human immunodeficiency virus enhances hepatitis C virus replication by differential regulation of IFN and TGF family genes. |
| Q34824481 | Pathogen-pathogen interaction: a syndemic model of complex biosocial processes in disease |
| Q58715600 | Signature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection |
| Q34359120 | Silibinin inhibits HIV-1 infection by reducing cellular activation and proliferation |
| Q26864344 | The Role of Sexually Transmitted Infections in HIV-1 Progression: A Comprehensive Review of the Literature |
| Q34103186 | The hepatitis C virus 5'UTR genomic region remains highly conserved under HAART: a 4- to 8-year longitudinal study from HCV/HIV co-infected patients |
| Q35812034 | The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin |
| Q38900456 | Virologic and immunologic aspects of HIV-hepatitis C virus coinfection |
Search more.